Stability of an extemporaneous alcohol-free melatonin suspension

American Journal of Health-System Pharmacy

Volumn 68, Issue 5, 2011, Pages 420-423

  Johnson, Cary E ^a,b   Cober, Mary Petrea ^c,d   Thome, Tennille ^e   Rouse, Emily ^e  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN HOSPITALS   (United States)

^c AKRON CHILDREN'S HOSPITAL   (United States)

^d NORTHEAST OHIO MEDICAL UNIVERSITY   (United States)

^e Department of Pharmacy Practice   (United States)

Author keywords

Anxiolytics, sedatives, and hypnotics; Chromatography, liquid; Color; Compounding; Concentration; Melatonin; Odors; Pyridoxine hydrochloride; Stability; Storage; Suspensions; Taste; Vehicles; Vitamins

Indexed keywords

AMBER; MELATONIN; PLASTIC; PYRIDOXINE;

ARTICLE; COLOR; DRUG STABILITY; DRUG SYNTHESIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ODOR; POWDER; PRESCRIPTION; PRIORITY JOURNAL; ROOM TEMPERATURE; SUSPENSION; TABLET FORMULATION; TASTE;

EID: 79956007854     PISSN: 10792082     EISSN: 15352900     Source Type: Journal    
DOI: 10.2146/ajhp100274     Document Type: Article

References (10)

1. Bendz LM, Scates AC. Melatonin treatment for insomnia in pediatric patients with attention-deficit/hyperactivity disorder. Ann Pharmacother. 2010; 44:185-91.
2. Sack RL, Lewy AJ, Hughes RJ. Use of melatonin for sleep and circadian rhythm disorders. Ann Med. 1998; 30:115-21. (Pubitemid 28154506)
3. Owens JA, Rosen CL, Mindell JA et al. Use of pharmacotherapy for insomnia in child psychiatry practice: a national survey. Sleep Med. 2010; 11:692-700.
4. American Academy of Pediatrics Committee on Drugs. Ethanol in liquid preparations intended for children. Pediatrics. 1984; 73:405-7.
5. Ebadi M. Regulation and function of pyridoxal phosphate in CNS. Neurochem Int. 1981; 3:181-205.
6. Hochberg M, Melnick D, Oser B. On the stability of pyridoxine. J Biol Chem. 1944; 155:129-36.
7. Shah T, Tse A, Gill H et al. Administration of melatonin mixed with soft food and liquids for children with neurodevelopmental difficulties. Dev Med Child Neurol. 2008; 50:845-9.
8. Cavello A, Hassan M. Stability of melatonin in aqueous solution. J Pineal Res. 1995; 2:90-2.
9. Haywood A, Burrell A, van Breda K et al. Stability of melatonin in an extemporaneously compounded sublingual solution and hard gelatin capsule. Int J Pharmaceut Compound. 2009; 13:170-4.
10. Saracino MA, Mercolini L, Musenga A et al. Comparison of analytical methods for the quality control of a new formulation containing soy extract and melatonin. J Sep Sci. 2008; 10:1851-9. (Pubitemid 351911748)